Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (the ACUTE Multicenter Study)

American Journal of Cardiology

Volumn 81, Issue 7, 1998, Pages 877-883

  Klein, Allan L ^a   Asinger, Richard W ^b   Black, Ian W ^b   Davidoff, Ravin ^b   Erbel, Raimund ^b   Halperin, Jonathan L ^b   Orsinelli, David A ^b   Porter, Thomas R ^b   Stoddard, Marcus F ^b   Arheart, Kristopher L ^b   Grimm, Richard A ^b   Murray, R Daniel ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; EMBOLISM; HEART VENTRICLE FIBRILLATION; HUMAN; METHODOLOGY; MULTICENTER STUDY; PRIORITY JOURNAL; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

EID: 0032054316     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00007-1     Document Type: Article

References (30)

1. 1. Klein AL, Grimm RA, Black IW, Leung DY, Chung MK, Vaughn SE, Murray RD, Miller DP, Arheart KL. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of cardioversion using transesophageal echocardiography. Ann Intern Med 1997; 126:200-209.
2. 2. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5 year study. J Am Coll Cardiol 1995;25:1354-1361.
3. 3. Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995;129:1204-1215.
4. 4. Prystowsky EN. Management of atrial fibrillation: simplicity surrounded by controversy (lett). Ann Intern Med 1997;126:244-246.
5. 5. Klein AL, Murray RD, Grimm RA. Management of atrial fibrillation: simplicity surrounded by controversy - reply to EN Prystowsky (lett) Ann Intern Med 1997;127:652-653.
6. 6. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 1992;102:426S-433S.
7. 7. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995;108:352S-359S.
8. 8. Prystowsky EN, Benson DW, Jr., Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996;93:1262-1277.
9. 9. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD, Lewis RP, Pearlman AS et al. ACC/AHA guidelines for the clinical application of echocardiography:executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). J Am Coll Cardiol 1997;29:862-879.
10. 10. Klein A, Miller D, Grimm R, Murray RD, Leung DY, Arheart K, Scalia G, Stewart W. Model of clinical endpoints for the assessment of cardioversion utilizing transesophageal (ACUTE) clinical trial (abstr). J Am Soc Echocardiogr 1996;9:387.
11. 11. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland G, Grube E, Hanrath P, Maisch B, Dennig K, Schartl M, Kremer P, Angermann C, Iliceto S, Curtius JM, Mugge A. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991; 83: 817-821.
12. 12. SPAF Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;1 16:6-12.
13. 13. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89:724-730.
14. 14. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski PN, Nikutta P, Lichtlen PR. Left atrial spontaneous contrast in mitral valve disease: an indicator for increased thromboembolic risk. J Am Coll Cardiol 1988;11: 1204-1211.
15. 15. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol 1985;6:744-749.
16. 16. Sadoshima J, Koyanagi S, Sugimachi M, Hirooka Y, Takeshita A. Evaluation of the severity of mitral regurgitation by transesophageal Doppler flow echocardiography. Am Heart J 1992;123:1245-1251.
17. 17. Chopra HK, Nanda NC, Fan P, Kapur KK, Goyal R, Daruwalla D, Pacifico A. Can two-dimensional echocardiography and Doppler color flow mapping identify the need for tricuspid valve repair? J Am Coll Cardiol 1989;14:1266-1274.
18. 18. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359-1366.
19. 19. Manning WJ, Silverman DI, Douglas PS. Thromboembolism after negative TEE. Circulation 1994;90:3121-3122.
20. 20. Black IW, Hopkins AP, Lee LC, Walsh WF. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993;126:375-381.
21. 21. Bjerkelund C, Orning OM. An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scandin 1968;184:481-491.
22. 22. McCarthy C, Varghese PJ, Barritt DW. Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up. Br Heart J 1969; 31:496-500.
23. 23. Roy D, Marchand E, Gagne P, Chabot M, Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986;112:1039-1043.
24. 24. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989;13:617-623.
25. 25. Stoddard ME, Longaker RA. Role of transesophageal echocardiography prior to cardioversion in patients with atrial fibrillation. J Am Coll Cardiol 1993;21: 28 A.
26. 26. Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, Walsh W, Feneley M. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996;77:321-327.
27. 27. Schweizer P, Bardos P, Erbel R, Meyer J, Merx W, Messmer BJ, Effert S. Detection of left atrial thrombi by echocardiography. Br Heart J 1981;45:148-156.
28. 28. Bansal RC, Heywood T, Appelgate PM, Jutzy KR. Detection of left atrial thrombi by two-dimensional echocardiography and surgical correlation in 148 patients with mitral valve disease. Am J Cardiol 1989;64:243-246.
29. 29. Leung DY, Grimm RA, Klein AL. Transesophageal echocardiographyguided approach to cardioversion of atrial fibrillation. Progr Cardiovasc Dis 1996;39:21-32.
30. 30. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556.